A medication that lowers that risk doesnt just treat joint pain it changes long-term survival
The risk of persistent glycemic disorders and SID increases with long-term or high-dose GCs use, mainly in oncological patients and patients treated for rheumatic and connective tissue disorders (25)
Cost sensitivity influences treatment duration, adherence rates, and prescribing decisions
Contact your GP if taste changes cause persistent vomiting, dehydration, excessive weight loss, severe abdominal pain, or significantly impact nutritional status or quality of life
Taken together, the data in the literature indicate that GLP-1R signaling in ARC may be a major contributor to the homeostatic effects of GLP-1 analogs on feeding, whereas other brain regions such as the brainstem may play a minor role